What was the market valuation of the UK immortalized cell-line market in 2024?

The market valuation was $307.22 Million in 2024. Read More

What is the projected market valuation for the UK immortalized cell-line market by 2035?

The projected valuation for 2035 is $600.0 Million. Read More

What is the expected CAGR for the UK immortalized cell-line market during the forecast period 2025 - 2035?

The expected CAGR during the forecast period is 6.27%. Read More

Which companies are considered key players in the UK immortalized cell-line market?

Key players include Thermo Fisher Scientific, Merck KGaA, Lonza Group, Corning Incorporated, Sigma-Aldrich, ATCC, Biosciences, and Cell Biolabs. Read More

What are the main methods used in the UK immortalized cell-line market and their valuations?

Main methods include Virus Induction ($50.0 - $100.0 Million), hTERT Expression ($80.0 - $150.0 Million), and Inactivation of Tumor Suppression Genes ($60.0 - $120.0 Million). Read More

What applications dominate the UK immortalized cell-line market?

Dominant applications include Drug Discovery ($80.0 - $150.0 Million) and Diagnostics ($50.0 - $100.0 Million). Read More

What are the end-user segments in the UK immortalized cell-line market?

End-user segments include Pharmaceutical and Biopharmaceutical Companies ($120.0 - $240.0 Million) and Contract Research Organizations ($90.0 - $180.0 Million). Read More

How does the market for vaccine production in the UK immortalized cell-line market perform?

The market for vaccine production is valued between $40.0 and $80.0 Million. Read More

What is the valuation range for the 'Others' segment in the method category?

The 'Others' segment in the method category is valued between $117.22 and $230.0 Million. Read More

What trends are expected to shape the UK immortalized cell-line market in the coming years?

Trends may include increased investment in research and development, driven by the anticipated growth in applications and end-user demand. Read More

UK Immortalized Cell Line Market

UK Immortalized Cell Line Market Research Report: Size, Share, Trend Analysis By Method (Virus Induction, HTERT Expression, Inactivation of Tumor Suppression Genes, others), By Applications (Diagnostics, Drug Discovery, Vaccine Production, Tissue Engineering, Regenerative Medicines, others) and By End Users (Pharmaceutical and Biopharmaceutical Companies, Contract Research Organizations, Research Laboratories) - Growth Outlook & Industry Forecast 2025 To 2035

Forecast Period

2025 - 2035

CAGR

6.27%

2024 Market Size

$ 307.22 Million

2035 Market Size

$ 600 Million

Life Sciences ● Updated April 2026 Report ID: MRFR/LS/52760-HCR | Pages: 200 | Author: Vikita Thakur, Garvit Vyas

Summary Table of Contents Segmentation Download PDF

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Construction, BY Method (USD Million)
  1. 4.1.1 Virus Induction
  2. 4.1.2 hTERT Expression
  3. 4.1.3 Inactivation of Tumor Suppression Genes
  4. 4.1.4 Others
2. 4.2 Construction, BY Application (USD Million)
  1. 4.2.1 Diagnostics
  2. 4.2.2 Drug Discovery
  3. 4.2.3 Vaccine Production
  4. 4.2.4 Tissue Engineering and Regenerative Medicine
  5. 4.2.5 Others
3. 4.3 Construction, BY End User (USD Million)
  1. 4.3.1 Pharmaceutical and Biopharmaceutical Companies
  2. 4.3.2 Contract Research Organizations
  3. 4.3.3 Research Laboratories
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Construction
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Construction
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Thermo Fisher Scientific (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Merck KGaA (DE)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Lonza Group (CH)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Corning Incorporated (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Sigma-Aldrich (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 ATCC (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Biosciences (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Cell Biolabs (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 UK MARKET ANALYSIS BY METHOD
3. 6.3 UK MARKET ANALYSIS BY APPLICATION
4. 6.4 UK MARKET ANALYSIS BY END USER
5. 6.5 KEY BUYING CRITERIA OF CONSTRUCTION
6. 6.6 RESEARCH PROCESS OF MRFR
7. 6.7 DRO ANALYSIS OF CONSTRUCTION
8. 6.8 DRIVERS IMPACT ANALYSIS: CONSTRUCTION
9. 6.9 RESTRAINTS IMPACT ANALYSIS: CONSTRUCTION
10. 6.10 SUPPLY / VALUE CHAIN: CONSTRUCTION
11. 6.11 CONSTRUCTION, BY METHOD, 2024 (% SHARE)
12. 6.12 CONSTRUCTION, BY METHOD, 2024 TO 2035 (USD Million)
13. 6.13 CONSTRUCTION, BY APPLICATION, 2024 (% SHARE)
14. 6.14 CONSTRUCTION, BY APPLICATION, 2024 TO 2035 (USD Million)
15. 6.15 CONSTRUCTION, BY END USER, 2024 (% SHARE)
16. 6.16 CONSTRUCTION, BY END USER, 2024 TO 2035 (USD Million)
17. 6.17 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 UK MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY METHOD, 2025-2035 (USD Million)
  2. 7.2.2 BY APPLICATION, 2025-2035 (USD Million)
  3. 7.2.3 BY END USER, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

UK Construction Market Segmentation

Construction By Method (USD Million, 2025-2035)

Virus Induction
hTERT Expression
Inactivation of Tumor Suppression Genes
Others

Construction By Application (USD Million, 2025-2035)

Diagnostics
Drug Discovery
Vaccine Production
Tissue Engineering and Regenerative Medicine
Others

Construction By End User (USD Million, 2025-2035)

UK Immortalized Cell Line Market and Biopharmaceutical Companies
Contract Research Organizations
Research Laboratories

Certified Researchers

Customize Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

“The Automotive 48V ECU Components Procurement Intelligence Study” was a complex project, but the Market Research Future (MRFR) team handled it with quality, agility, and customer-centricity. They delivered all requested data on time and within the agreed scope. The team, including Shubhendra Anand and Rahul Gotadki, was always readily available to clarify questions and swiftly implement necessary adjustments, driving the project to a successful conclusion within a very demanding timeframe.
I would also like to specifically commend Akshay Agarwal for his responsiveness and support at every stage—from our initial inquiry on May 6th through to final delivery on June 18th. His dedication made the entire process seamless.”